Q1 2021 G1 Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the G1 Therapeutics 2021 first quarter financial results conference call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. (Operator Instructions). I would now like to hand the conference over to our speaker today, Mr. Will Roberts, please go ahead.
Thank you Julian. Good afternoon everyone and welcome to the G1 conference call to discuss our first quarter 2021 financial results and business update. The press release on these financial results was issued after market close this afternoon and can be found in the news section of our corporate website, g1therapeutics.com. On this afternoon's call, the team will provide a business overview of the first quarter, including an update on our launch progress with COSELA, which was approved by the US Food and Drug Administration on February 12th, 2021 to decrease the incidence of chemotherapy
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |